Skip to main content
Top

memo - Magazine of European Medical Oncology

An International Journal for Oncology and Haematology Professionals

2008 - 2024
Volumes
145
Issues
Chevron right icon
Issue 3/2024
Latest issue

About this journal

The focus of the journal "magazine of european medical oncology – memo" is to offer a professional review on current research and development in the field of hematology and oncology relevant for daily practice. Therefore, memo includes editorials and comments, peer-reviewed original reports, short reviews, case reports and controversies, articles explaining the biology of neoplasia and congress reports including qualified comments. As a European journal memo aims at highlighting the local peculiarities of various regions and at being a forum for the presentation of ongoing clinical and basic research.

memo is the Official Journal of the Central European Cooperative Oncology Group (CECOG) and The Austrian Society of Haematology and Oncology (OeGHO).

Metadata
Title
memo - Magazine of European Medical Oncology
Coverage
Volume 1/2008 - Volume 17/2024
Publisher
Springer Vienna
Electronic ISSN
1865-5076
Print ISSN
1865-5041
Journal ID
12254
DOI
https://doi.org/10.1007/12254.1865-5076

2024 ESMO Congress

SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

  • Webinar | 01-10-2024 | 12:30 (CEST)

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Get a reminder for the on-demand version